Massot C, Vanderpas J
Observatoire de Santé Rue Saint Antoine 1, B-7021 Havré, Mons.
Acta Clin Belg. 2003 May-Jun;58(3):169-77. doi: 10.1179/acb.2003.58.3.004.
Anaemia during pregnancy is a common problem worldwide. In industrialised countries, it is still frequent in some groups of population. This study is based on the retrospective analysis of results of routine blood analysis performed on 15-44 years old women attending prenatal clinics (study group) or other outpatient clinics (non pregnant group) in a public hospital in Mons, Belgium from 1997 to 1999. In the non-pregnant group (2503 women), anaemia (haemoglobin < 12 g/dL) was present in 7.7% of the women. During pregnancy, anaemia was defined as haemoglobin level < 11 g/dL. In our sample, during the 1st trimester of pregnancy, anaemia was present in 4.3% of 887 pregnancies, among which 35% meeting CDC criteria (ferritin < 12 micrograms/L) for iron deficiency anaemia (IDA). Frequency of anaemia increases through pregnancy. Among 1313 pregnancies, 31% suffer from anaemia during the 3rd trimester, among which 75% meet criteria for IDA. Both low haemoglobin and low ferritin levels during the 1st trimester are good predictors of 3rd trimester anaemia. Systematic administration of iron supplement during pregnancy is matter of debate. In order to limit supplementation to pregnant women at risk of 3rd trimester anaemia, we suggest to treat anaemia (haemoglobin level < 11 g/d) detected at the first prenatal visit and to give small doses of iron (30 mg per day) when haemoglobin level is between 11 g/dL and 13 g/dL or ferritin level is less than 20 micrograms/dL. Low doses are generally well tolerated and compliance is better.
孕期贫血是一个全球性的常见问题。在工业化国家,某些人群中贫血现象仍很常见。本研究基于对1997年至1999年期间在比利时蒙斯一家公立医院产前诊所就诊的15至44岁女性(研究组)或其他门诊诊所(非孕组)进行的常规血液分析结果的回顾性分析。在非孕组(2503名女性)中,7.7%的女性存在贫血(血红蛋白<12 g/dL)。孕期贫血定义为血红蛋白水平<11 g/dL。在我们的样本中,妊娠早期,887例妊娠中有4.3%存在贫血,其中35%符合美国疾病控制与预防中心(CDC)缺铁性贫血(IDA)标准(铁蛋白<12微克/升)。贫血发生率在孕期会增加。在1313例妊娠中,31%在妊娠晚期患贫血,其中75%符合IDA标准。妊娠早期血红蛋白和铁蛋白水平低都是妊娠晚期贫血的良好预测指标。孕期系统性补充铁剂存在争议。为了将补充剂限制在有妊娠晚期贫血风险的孕妇中,我们建议治疗首次产前检查时发现的贫血(血红蛋白水平<11 g/d),当血红蛋白水平在11 g/dL至13 g/dL之间或铁蛋白水平低于20微克/分升时给予小剂量铁剂(每天30毫克)。小剂量通常耐受性良好且依从性更好。